IMMA health

Company Overview

Snapshot

Founded in January 2021 by Beatrice Chemla and Nadia Prisant, IMMA health operates with 1–10 employees. The company has raised $3.6M across three funding rounds from two investors. In September 2025, IMMA health secured funding from Ixcore and Israel Innovation Authority.

Business overview

IMMA health is an Israeli venture focused on women's pelvic health, developing an automated solution for at-home transvaginal self-scanning. The company's core technology includes a remote, easy-to-use ultrasound device integrated with AI-powered image analysis and a dedicated mobile application. IMMA health serves the digital healthcare and medical devices sectors, enabling women to perform self-scans in the comfort of their homes. Its platform is designed to be scalable for various indications across a woman's life, including IVF, natural fertility monitoring, hormone-free contraception, endometriosis, myomas, PCOS, cervix length monitoring, and early cancer screening. The initial focus is on the fertility journey, aiming to enhance access to the IVF market and improve success rates through personalized, remote monitoring.

Strategic signal

In September 2025, IMMA health secured funding from Ixcore and Israel Innovation Authority, which was highlighted in a CTech article. This investment signals continued confidence in IMMA health's innovative approach to at-home transvaginal ultrasound technology, particularly for IVF patients. It suggests a strong market validation for their AI-powered solution and indicates a positive trajectory for expanding access to women's pelvic health diagnostics and monitoring.

Company Intelligence Q&A

What is IMMA health's primary focus?

IMMA health is developing the first automated solution for at-home transvaginal self-scanning, leveraging an easy-to-use ultrasound device with AI-powered image analysis and a dedicated app to empower women in managing their pelvic health.

When was IMMA health founded and by whom?

IMMA health was founded in January 2021 by Beatrice Chemla and Nadia Prisant.

What significant funding did IMMA health receive in September 2025?

In September 2025, IMMA health secured funding from Ixcore and Israel Innovation Authority, as reported by CTech.

What was a notable achievement for IMMA health in April 2025?

In April 2025, IMMA health won the 'Best Team' award at The Ventures Israel in Tel Aviv, where the company pitched its innovations in AI, robotics, and digital health.

What recognition did IMMA health receive in December 2024?

In December 2024, IMMA health, led by CEO and co-founder Beatrice Chemla, was celebrated at the FemTech 2024 summit for its groundbreaking work in women's health technology, addressing the gender gap in tech.